Cargando…

A Critical Overview of Interleukin 32 in Leishmaniases

Interleukin-32 (IL-32) has several immune regulatory properties, which have driven its investigation in the context of various diseases. IL-32 expression is reported to be induced in the lesions of patients with American tegumentary leishmaniasis (ATL) by the New World Leishmania spp. that are respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro-Dias, Fátima, Oliveira, Iara Barreto Neves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927017/ https://www.ncbi.nlm.nih.gov/pubmed/35309341 http://dx.doi.org/10.3389/fimmu.2022.849340

Ejemplares similares

An overview of the sand fly salivary proteins in vaccine development against leishmaniases
por: Fayaz, Shima, et al.
Publicado: (2022)

Global distribution maps of the leishmaniases
por: Pigott, David M, et al.
Publicado: (2014)

A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
por: Shim, Saerok, et al.
Publicado: (2022)

The leishmaniases in Kenya: A scoping review
por: Grifferty, Grace, et al.
Publicado: (2023)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Leishmaniases in the European Union and Neighboring Countries
por: Berriatua, Eduardo, et al.
Publicado: (2021)

Vaccines for the Leishmaniases: Proposals for a Research Agenda
por: Costa, Carlos Henrique Nery, et al.
Publicado: (2011)

Interleukin-32 as a biomarker in rheumatic diseases: A narrative review
por: Kwon, Oh Chan, et al.
Publicado: (2023)

Management of Leishmaniases in the Era of Climate Change in Morocco
por: Kholoud, Kahime, et al.
Publicado: (2018)

Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity
por: Shim, Saerok, et al.
Publicado: (2022)

Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review
por: Grifferty, Grace, et al.
Publicado: (2021)

Comparative genomics: From genotype to disease phenotype in the leishmaniases
por: Smith, Deborah F., et al.
Publicado: (2007)

Leishmaniases diagnosis: an update on the use of immunological and molecular tools
por: de Paiva-Cavalcanti, Milena, et al.
Publicado: (2015)

Leishmania tarentolae: A new frontier in the epidemiology and control of the leishmaniases
por: Mendoza‐Roldan, Jairo Alfonso, et al.
Publicado: (2022)

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
por: Kourbeli, Violeta, et al.
Publicado: (2021)

Editorial: Leishmania genome variability: Impacts on parasite evolution, parasitism and leishmaniases control
por: Tosi, Luiz R. O., et al.
Publicado: (2023)

Interleukin-32γ in the Control of Acute Experimental Chagas Disease
por: Braga, Yarlla L. L., et al.
Publicado: (2022)

Persistence and Changing Distribution of Leishmaniases in Kenya Require a Paradigm Shift
por: Ouma, Francan F., et al.
Publicado: (2021)

In Vitro Antiparasitic Activities of Monovalent Ionophore Compounds for Human and Canine Leishmaniases
por: Calvo Alvarez, Estefanía, et al.
Publicado: (2022)

Leishmaniases' Burden of Disease: Ways Forward for Getting from Speculation to Reality
por: Reithinger, Richard
Publicado: (2008)

Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases
por: Cruz, Israel, et al.
Publicado: (2019)

Utilising a novel surveillance system to enhance field screening activities for the leishmaniases
por: Panahi, Elina, et al.
Publicado: (2020)

PREVALENCE OF AMERICAN TRYPANOSOMIASIS AND LEISHMANIASES IN DOMESTIC DOGS IN A RURAL AREA OF THE MUNICIPALITY OF SÃO JOÃO DO PIAUÍ, PIAUÍ STATE, BRAZIL
por: PEREZ, Taliha Dias, et al.
Publicado: (2016)

Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases
por: Lanza, Juliane S., et al.
Publicado: (2022)

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
por: Monteiro, Lis Marie, et al.
Publicado: (2017)

One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools
por: Hong, Ahyun, et al.
Publicado: (2020)

Applied Machine Learning Toward Drug Discovery Enhancement: Leishmaniases as a Case Study
por: Harigua-Souiai, Emna, et al.
Publicado: (2022)

Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
por: Tulloch, Lindsay B., et al.
Publicado: (2009)

Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme
por: Deb, Rinki, et al.
Publicado: (2021)

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review
por: Rocha, Rafael, et al.
Publicado: (2022)

Interleukin-32: Frenemy in cancer?
por: Han, Sora, et al.
Publicado: (2019)

Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum
por: Lévêque, Maude F., et al.
Publicado: (2020)

Recombinant Antigens from Phlebotomus perniciosus Saliva as Markers of Canine Exposure to Visceral Leishmaniases Vector
por: Drahota, Jan, et al.
Publicado: (2014)

Recombinant Leishmania infantum Heat Shock Protein 83 for the Serodiagnosis of Cutaneous, Mucosal, and Visceral Leishmaniases
por: Celeste, Beatriz Julieta, et al.
Publicado: (2014)

Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases
por: Reis, Luiza C., et al.
Publicado: (2021)

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
por: Nagle, Advait, et al.
Publicado: (2020)

Lipophosphoglycan From Dermotropic New World Leishmania Upregulates Interleukin-32 and Proinflammatory Cytokines Through TLR4 and NOD2 Receptors
por: Silveira, Murilo Barros, et al.
Publicado: (2022)

Interleukin-32 in Inflammatory Autoimmune Diseases
por: Kim, Soohyun
Publicado: (2014)

The Biology and Role of Interleukin-32 in Tuberculosis
por: Li, Wu, et al.
Publicado: (2018)

Interleukin 32 expression in human melanoma
por: Paz, Helicia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfrmq85ob4rab0giujfuqgtruu